EP 1178827 A1 20020213 - USE OF ANTIBODIES IDENTIFYING THE INTERLEUKIN-2 RECEPTOR FOR PREVENTING AND/OR TREATING HIV INFECTIONS
Title (en)
USE OF ANTIBODIES IDENTIFYING THE INTERLEUKIN-2 RECEPTOR FOR PREVENTING AND/OR TREATING HIV INFECTIONS
Title (de)
VERWENDUNG VON ANTIKÖRPERN GEGEN DEN INTERLEUKIN-2-REZEPTOR ZUR VORBEUGUNG UND/ODER ZUR BEHANDLUNG VON INFEKTIONEN DURCH AIDS-VIRUSEN
Title (fr)
UTILISATION D'ANTICORPS RECONNAISSANT LE RECEPTEUR DE L'INTERLEUKINE-2 DANS LA PREVENTION ET/OU LE TRAITEMENT DES INFECTIONS PAR LES VIRUS DU SIDA.
Publication
Application
Priority
- FR 0001399 W 20000522
- FR 9906528 A 19990521
Abstract (en)
[origin: FR2793691A1] Using antibodies, or their fragments or analogs that recognize sub-units alpha , beta , and psi of interleukin (IL)-2 receptors, in medicines for the prevention and treatment of mammalian immunodeficiency virus (IV), especially human (H)IV, simian (S)IV, and feline (F)IV, is new. Using antibodies, or their fragments or analogs that recognize sub-units alpha , beta , and psi of interleukin (IL)-2 receptors, in medicines for the prevention and treatment of mammalian immunodeficiency virus (IV), especially human (H)IV, simian (S)IV, and feline (F)IV, is new. The antibodies prevent fixation of the virus on target cells by steric hindrance. The antibody analogs are peptides which mimic antibody paratopes or which are capable of fixing themselves to the defined IL-2 subunits.
IPC 1-7
IPC 8 full level
A61P 31/12 (2006.01); A61P 31/18 (2006.01); C07K 16/28 (2006.01)
CPC (source: EP)
A61P 31/12 (2017.12); A61P 31/18 (2017.12); C07K 16/2866 (2013.01); A61K 2039/505 (2013.01)
Citation (search report)
See references of WO 0071159A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT
DOCDB simple family (publication)
FR 2793691 A1 20001124; FR 2793691 B1 20031003; AP 2001002354 A0 20011231; AU 4930300 A 20001212; CA 2373991 A1 20001130; EA 200101228 A1 20020829; EP 1178827 A1 20020213; OA 12311 A 20060512; WO 0071159 A1 20001130
DOCDB simple family (application)
FR 9906528 A 19990521; AP 2001002354 A 20000522; AU 4930300 A 20000522; CA 2373991 A 20000522; EA 200101228 A 20000522; EP 00931335 A 20000522; FR 0001399 W 20000522; OA 1200100307 A 20000522